Gallbladder shown as potential stem cell source for regenerative liver and metabolic disease

April 19, 2012

A new study presented today at the International Liver Congress 2012 indicates the potential for gallbladder tissue (which is routinely discarded from organ donors and surgical interventions) to be a highly available candidate source for multipotential stem cells.

Biliary tree stem/progenitor cells (BTSCs) have previously been identified in the glands of normal adult human extrahepatic and been shown to generate in vitro and in vivo of the hepato-biliary and pancreatic endocrine lineages.

The study found both normal and pathological gallbladders contained easily isolable cells with the phenotype and biological properties of BTSCs. Interestingly, in an animal model, these cells were able to repopulate the injured liver and to improve synthetic functions.

These data open novel perspectives for the collection and use of in regenerative therapies of liver, bile duct, and pancreatic diseases including diabetes.

Explore further: Restoring what's lost: Uncovering how liver tissue regenerates

More information: Carpino G et al., Gallbladder is a highly available source of stem cells with multiple endodermic mature gates potentiality. Abstract presented at the International Liver Congress 2012

Related Stories

Recommended for you

Utah man may have contracted Zika from dying father's tears

September 29, 2016

A Utah man who mysteriously contracted Zika from his infected father may have got it by touching his dad's tears or sweat with his bare hands, according to new research unveiled Wednesday that found the unusual transmission ...

Acne sufferers' cells may be protected against aging

September 28, 2016

Scientists at King's College London have found that people who have previously suffered from acne are likely to have longer telomeres (the protective repeated nucleotides found at the end of chromosomes) in their white blood ...

Antibiotics developed in 1960s show promise for TB therapy

September 28, 2016

First generation cephalosporins—antibiotics introduced as a treatment against bacterial infections in 1963—now show promise for tuberculosis (TB) therapy, according to new research published in Scientific Reports.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.